Karen Marie Johnson bought $38k of STLN
director at Oncology Institute, Inc.. 36,224 shares at an average of $1.04, traded Mar 26, 2025, filed Mar 28, 2025.
Score components
- +15RoleDirector
- +6Trade size$38k at market
- +6Relative to holdingsHoldings up 22%
- 0Price contextNear the top of the 52-week range
- +15Cluster5 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +190.4%, 3m +92.1%, 6m +210.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001079973-25-000523, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 26, 2025 | POpen-market purchase Common Stock | +36,224 | $1.04 | $38k | 203,409 | Mar 28, 2025 |
| Mar 26, 2025 | POpen-market purchase Common Warrantderivative | +18,112 | $0.13 | $2,264 | 18,112 | Mar 28, 2025 |
Related signals
Other insiders at Oncology Institute, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | Oncology Institute, Inc. | Brad Hively director | $1.9M 298,853 shares | -42% | |
| 26Weak | STLNbuy Oncology Institute, Inc. | Jorey Chernett owner | $78k 12,000 shares | +0% | |
| 27Weak | STLNbuy Oncology Institute, Inc. | Jorey Chernett owner | $95k 18,000 shares | +0% | |
| 0Weak | Oncology Institute, Inc. | Yale Podnos Chief Medical Officer | $150k 23,452 shares | -8% | |
| 26Weak | STLNbuy Oncology Institute, Inc. | Jorey Chernett owner | $88k 15,000 shares | +0% | |
| 16Weak | STLNbuy Oncology Institute, Inc. | Jorey Chernett owner | $90k 18,000 shares | +0% | |
| 6Weak | Oncology Institute, Inc. | Yale Podnos Chief Medical Officer | $126k 23,451 shares | -8% | |
| 14Weak | STLNbuy Oncology Institute, Inc. | Jorey Chernett owner | $57k 12,000 shares | +0% | |
| 18Weak | STLNbuy Oncology Institute, Inc. | Jorey Chernett owner | $157k 38,500 shares | +0% | |
| 17Weak | STLNbuy Oncology Institute, Inc. | Jorey Chernett owner | $123k 30,000 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.